Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27617414 | 0.87 | AKR1C3 (0.57) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL809324 | 0.86 | AKR1C3 (0.72) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL1647825 | 0.85 | AKR1C3 (0.64) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL6056938 | 0.84 | AKR1C3 (0.69) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL6057040 | 0.84 | AKR1C3 (0.69) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL22939141 | 0.83 | HPGD (0.55) | AKR1C3MEN1KMT2AKDM4ELMNA | |
| SCHEMBL28318689 | 0.82 | GAA (0.56) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL78196 | 0.82 | GAA (0.56) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL29557032 | 0.82 | GAA (0.56) | AKR1C3GAAMEN1USP2KMT2A | |
| SCHEMBL8935427 | 0.81 | ALDH1A1 (0.65) | AKR1C3GAAMEN1USP2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | claimed |
| EP-3801880-A1 | METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFS), COVALENT ORGANIC FRAMEWORKS (COFS) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFS), AND APPLICATIONS THEREOF | Desiccant Rotors International Private Ltd. (IN) | 2021-04-14 | — | — | EP | claimed |
| US-20210016245-A1 | METHOD FOR IN-SITU SYNTHESIS OF METAL ORGANIC FRAMEWORKS (MOFs), COVALENT ORGANIC FRAMEWORKS (COFs) AND ZEOLITE IMIDAZOLATE FRAMEWORKS (ZIFs), AND APPLICATIONS THEREOF | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2021-01-21 | — | — | US | claimed |
| US-20200291045-A1 | CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-09-17 | — | — | US | claimed |
| US-20240197868-A1 | IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS | UNIVERSITE DE VERSAILLES-SAINT-QUENTIN-EN-YVELINES (FR) | 2024-06-20 | — | — | US | disclosed |
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | disclosed |
| WO-2024123909-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | disclosed |
| EP-4313133-A2 | IMMUNOGENIC COMPOSITION CONTAINING AN ANTIGEN AND AN ADJUVANT COMPRISING AL-MOFS | UNIVERSITE DE VERSAILLES-SAINT QUENTIN EN YVELINES (FR) | 2024-02-07 | — | — | EP | disclosed |
| US-11891406-B2 | Conductivity enhancement of MOFs via development of MOFpolymer composite material | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-02-06 | — | — | US | disclosed |
| US-11767331-B2 | Water stable zinc-based metal organic framework and method of use | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2023-09-26 | — | — | US | disclosed |
| US-20100076220-A1 | NOVEL METAL ORGANIC FRAMEWORKS BASED ON ALUMINUM, IRON AND CHROMIUM | BASF SE (DE) | 2010-03-25 | — | — | US | disclosed |
| US-20090306420-A1 | PROCESS FOR PREPARING COPPER-COMPRISING METAL ORGANIC FRAMEWORKS | BASF SE (DE) | 2009-12-10 | — | — | US | disclosed |
| US-20090281341-A1 | METAL-ORGANIC ZIRCONIUM-BASED FRAMEWORK MATERIALS | BASF SE (DE) | 2009-11-12 | — | — | US | disclosed |
| US-20090198079-A1 | PROCESS FOR PREPARING METAL ORGANIC FRAMEWORKS COMPRISING METALS OF TRANSITION GROUP IV | BASF SE | 2009-08-06 | — | — | US | disclosed |
| US-20090171107-A1 | PROCESS FOR PREPARING POROUS METAL ORGANIC FRAMEWORKS | BASF SE (DE) | 2009-07-02 | — | — | US | disclosed |
| US-20080300387-A1 | Organometallic Framework Materials of Transition Group III | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| US-20080281116-A1 | Acid-Functionalized Organometallic Framework Materials | BASF SE (DE) | 2008-11-13 | — | — | US | disclosed |
| US-20080227634-A1 | porous metal-organic framework material for taking up at least one substance, the framework material comprising at least one at least bidentate organic compound bound by coordination to at least one metal ion, and the framework material having at least in part pores which comprise a polymer | BASF SE (DE) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090171107-A1 | PROCESS FOR PREPARING POROUS METAL ORGANIC FRAMEWORKS | OSTC, OGDH, SCO2 | AKR1C3 168/4885GAA 4308/4885MEN1 2489/4885 |
| US-20090306420-A1 | PROCESS FOR PREPARING COPPER-COMPRISING METAL ORGANIC FRAMEWORKS | AOC1, AOC2, AOC3 | AKR1C3 167/4885GAA 2574/4885MEN1 975/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.